MedPath

GRASTOFIL

GRASTOFIL

Approved
DIN Number

02454548

Drug Class

Human

Market Date

Nov 28, 2016

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02454548
AIG Number0123525003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L03AA02 FILGRASTIM
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous ,  Intravenous
AHFS Classification20:16.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

FILGRASTIMActive
Strength: 480 MCG / 0.8 ML
Monograph: FILGRASTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.